Brief: Astrazeneca Pharma India Gets Show Cause Notice From National Pharmaceutical Pricing Authority
12/09/2025 11:43
Sept 12 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS: ASTRAZENECA PHARMA INDIA - GETS SHOW CAUSE NOTICE FROM NATIONAL PHARMACEUTICAL PRICING AUTHORITY ASTRAZENECA PHARMA INDIA LTD - NPPA ALLEGES OVERCHARGING FOR 'SYMBICORT TURBUHALER' ASTRAZENECA PHARMA INDIA LTD - CLAIM QUANTUM 605 MILLION RUPEES Source text: ID:nNSEb5xzyw Further company coverage: ASTR.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication